ALL vs LMAT · P/E 4.9, $56.89B cap vs P/E 35, rev $219.9M
The Allstate Corporation (ALL) versus LeMaitre Vascular Inc (LMAT) — a side-by-side from cached financials, not a winner call.
The Allstate Corporation (ALL) is a insurance - property & casualty company listed on US.
LeMaitre Vascular Inc (LMAT) is a medical instruments & supplies company listed on US.
ALL does not have a complete income-statement cache yet.
Latest reported LMAT revenue for 2024-12-31 was $219.9M. Net income was $44.0M. Revenue was up 13.6% from 2023-12-31 to 2024-12-31. LMAT currently screens at market cap $2.16B and trailing P/E 34.8.
ALL currently screens at market cap $56.89B and trailing P/E 4.9. LMAT currently screens at market cap $2.16B and trailing P/E 34.8.
Not investment advice. Open the ALL and LMAT stock pages for the full models.
Not investment advice.